Drug Utilisation Study Of Proton Pumps Inhibitors In Inpatients Of A Tertiary Care Hospital: A Cross-Sectional Study
Drug Utilisation Study Of Proton Pumps Inhibitors
DOI:
https://doi.org/10.70284/njirm.v6i5.968Keywords:
Drug utilization, Cross-Sectional Studies, Inpatients, Proton Pump Inhibitors, Pantoprazole, Tertiary Healthcare. , MDAAbstract
Background & Objective: Drug utilization research studies are effective tools that help in evaluating the drug prescribing trends, efficiency of hospital formularies. Proton pump inhibitors (PPI) are one of the most frequently prescribed classes of drugs. However because of their High efficacy & easy availability irrational use and unnecessary exposure is high. This study is designed to identify such problems and to promote rational and judicious use of PPIs. Methodology: A retrospective cross-sectional study was conducted at the S.S Institute of Medical Science and Research, Davangere. Patient medical records with of PPIs prescription were analysed for drugs used including name of the drug, dosage schedule, duration of treatment and concomitant medication. Rationality of prescriptions was evaluated by referring to the indications of PPI use By National Formulary of India; 2011. Results: 216(54%) cases on PPI medications were selected to for our study. Pantoprazole was prescribed in majority of 68% followed by Rabiprazole 16%, Esmoprazole in 13% and then by Lansoprazole in 3% of patients. In our study indications for PPI prescriptions were acute gastritis (4%), GERD (5%), as preoperative medication (11%) and along with NSAIDS (24%) but majority 56 % of PPI prescriptions had no clear indication. Among concomitant drugs used, Antimicrobials were the most commonly (68%) used followed by nonsteroidal anti-inflammatory drugs (24%) and other drugs like Antihypertensive (9%) and Antiemetic (13%). Conclusion: PPIs are one of the most commonly prescribed drugs. But most of the prescriptions had no proper indications hence irrational. Creating awareness about judicious use of PPI is a necessity. [Patil R NJIRM 2015; 6(5):62-65]
References
2. ForgacsI, Loganayagam A: Overprescribing proton pump inhibitors. BMJ. 2008 Jan 5; 336(7634):2-3.
3. Heidelbaugh JJ, Kim AH, Chang R and Walker PC. Ther Adv Gastroenterol. 2012; 5(4)219–232.
4. Florentin M, Elisaf MS. Proton pump inhibitor-induced hypomagnesemia: A new challenge. World J Nephrol. 2012 Dec 6; 1(6):151–154.
5. Jianu CS, Fossmark R, Viset T, Qvigstad G, Sørdal O, Mårvik R et al. Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther. 2012 Oct; 36(7):644-9.
6. Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006; 296(24):2947–53.
7. Ramirez E, Lei S, Borobia A, Pinana E, FudioS, Munoz R, et al. Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital, Current Clinical Pharmacology. 2010; 5(4):288-97.
8. Kaur S, Rajagopalan S, Kaur N, Shafiq N, Bhalla A, Pandhi P et al.Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North India. Emergency Medicine International, vol. 2014, Article ID 973578, 5 pages, 2014.Volume 2014 (2014).
9. Mayet AY. Improper use of antisecretory drugs in tertiary care teaching hospital: An observational study. The Saudi Journal of Gastroenterology.2007; 13(3):124-8. doi.org/10.4103/1319-3767.33463.
10. National Formulary of India. [Internet] 2011, 4th edition. Available from:
http://www.cdsco.nic.in/writereaddata/NFI_2011%20(1).pdf
11. Nousheen, Tadvi NA, Shareef SM. Use of proton pump inhibitors in general practice: Is it rationale? Int J Med Res Health Sci. 2014;3(1):37-42.
12. Heidelbaugh JJ, Inadomi JM. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol. 2006 Oct; 101(10):2200-5.
13. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther. 2000; 25(5):333-40.
14. Mainie I, Tutuian R, Castell DO. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008 Jul; 42(6):676-9.
